TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/25 19:22 | 1/23/25 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Olukotun Adeoye Y | CA | D | S | -20 | 21.00 | 0 | -1 | -3 | 36 | D | |||||||||||||||
12/30/24 17:12 | 12/27/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Olukotun Adeoye Y | CA | D | S | -57 | 20.00 | 0 | -3 | -7 | 37 | D | |||||||||||||||
3/6/23 18:04 | 3/3/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Olukotun Adeoye Y | CA | D | S | -371 | 32.65 | 0 | -11 | -59 | 8 | D | |||||||||||||||
1/4/22 21:33 | 1/3/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Olukotun Adeoye Y | CA | D | S | -262 | 64.75 | 0 | -4 | -45 | 5 | D | |||||||||||||||
9/14/21 17:25 | 9/13/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Olukotun Adeoye Y | CA | D | S | -319 | 63.76 | 0 | -5 | -36 | 9 | D | |||||||||||||||
1/20/04 10:46 | 1/16/04 | ESPR | Esperion Therapeutics Inc/mi | DE | Health | Drug | Pharmaceutical Preparations | Olukotun Adeoye Y | MI | O | SVP Clin | S | -804 | 34.65 | 0 | -23 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |